Founded in 2016, Genes2Me operates in Health Tech offering innovative in vitro diagnostic solutions and genetic testing services. The company manufactures a range of advanced products including NGS cl...
Company Type:
Bootstrapped
Revenue:
₹21.7 Cr+ (FY25)
₹21.7 Cr+ (FY25)
Employee count:
118
Last 90d
118
Last 90d
Web traffic:
1.04K
1.04K
Last 30d
Last 30d
Glassdoor Rating:
Genes2me: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders3
Latest Filing Date30 March 2025- Funding Events5
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Genes2me
As of 31 March 2025, Genes2me's equity is held by 3 shareholders, with the top three being Neeraj Gupta, Ritu Gupta, and Imperial Life Sciences Private Limited.
Neeraj Gupta holds the largest stake in Genes2me at 47.5% as of 31 March 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links